Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Vora, Parvez  [Clear All Filters]
Journal Article
Vora P, Seyfrid M, Venugopal C, Qazi MA, Salim S, Isserlin R, Subapanditha M, O'Farrell E, Mahendram S, Singh M, et al. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells. J Neurooncol. 2019.
Qazi MA, Salim SK, Brown KR, Mikolajewicz N, Savage N, Han H, Subapanditha MK, Bakhshinyan D, Nixon A, Vora P, et al. Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma. Cell Rep. 2022;40(13):111420.
Vora P, Venugopal C, McFarlane N, Singh SK. Culture and Isolation of Brain Tumor Initiating Cells. Curr Protoc Stem Cell Biol. 2015;34:3.3.1-3.3.13.
Rahn JJ, Lun X, Jorch SK, Hao X, Venugopal C, Vora P, Ahn BYoung, Babes L, Alshehri MM, J Cairncross G, et al. Development of a peptide-based delivery platform for targeting malignant brain tumors. Biomaterials. 2020;252:120105.
Kieliszek AM, Mobilio D, Upreti D, Bloemberg D, Escudero L, Kwiecien JM, Alizada Z, Zhai K, Ang P, Chafe SC, et al. Intratumoral Delivery of Chimeric Antigen Receptor-T Cells Targeting CD133 Effectively Treats Brain Metastases. Clin Cancer Res. 2023.
Tripathi A, Parikh ZS, Vora P, Frost EE, Pillai PP. pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin. Cell Mol Neurobiol. 2016.
Vora P, Venugopal C, Salim SKhalid, Tatari N, Bakhshinyan D, Singh M, Seyfrid M, Upreti D, Rentas S, Wong N, et al. The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma. Cell Stem Cell. 2020.